Amir Ibrahim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amir Ibrahim has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Andrew J. Admon
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
1 shared publication - Evan Wood
University of British Columbia
1 shared publication - James Cameron Johnston
Department of Medicine, University of British Columbia , Vancouver, British Columbia
1 shared publication - John Mark FitzGerald
Centre for Lung Health, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, Canada
1 shared publication - Julio Sg Montaner
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
1 shared publication - Michael-John Milloy
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, Canada
1 shared publication
Latest Publications
- Open Access
- 22 October 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 266
Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting
Studies examining the transmission of multidrug-resistant tuberculosis (MDR-TB) strains have yielded conflicting results.
- 22 October 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 266
Open AccessLong term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting
Studies examining the transmission of multidrug-resistant tuberculosis (MDR-TB) strains have yielded conflicting results.
- Open Access
- 25 January 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 22
Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study
Background: Despite the availability of antiretroviral therapy (ART), suboptimal treatment outcomes have been observed among HIV-seropositive illicit drug users. As there is an urgent need to improve responses to antiretroviral therapy among this population, we undertook this study to evaluate the role of physician experience on rates of plasma HIV-1 RNA suppression following initiation of ART. Methods: Using data from a community-recruited cohort of HIV-positive illicit drug users, we used Cox proportional hazards regression to model the time to plasma viral HIV RNA < 500 copies/mL among antiretroviral-naïve subjects initiating ART. Physician experience was defined as a continuous variable measured per 100 HIV-infected patients previously enrolled in the province-wide HIV treatment registry by that physician at the time a patient was enrolled. Results: Between May 1996 and December 2008, 267 individuals initiated ART among whom 227 (85%) achieved a plasma HIV RNA < 500 copies/mL during the study period. In a multivariate analysis, greater physician experience was independently associated with higher rates of plasma HIV RNA suppression (adjusted hazard ratio [AHR] = 1.17, 95% confidence interval [CI]: 1.03-1.34) after adjustment for adherence to ART. Other factors associated with viral suppression included engagement in methadone maintenance therapy (AHR = 1.61, 95% CI: 1.23-2.09), ≥ 95% adherence to ART (AHR = 2.42, 95% CI: 1.80-3.26), baseline CD4 count (AHR = 0.89, 95% CI: 0.83-0.96) and baseline plasma HIV-1 RNA (AHR = 0.65, 95% CI: 0.53-0.81). Conclusions: In this setting of universal HIV/AIDS care, illicit drug users with more experienced physicians exhibited faster rates of plasma viral load suppression. These findings argue for specialized services to help optimize HIV treatment outcomes among this population.
- 25 January 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 22
Open AccessPhysician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study
Background: Despite the availability of antiretroviral therapy (ART), suboptimal treatment outcomes have been observed among HIV-seropositive illicit drug users. As there is an urgent need to improve responses to antiretroviral therapy among this population, we undertook this study to evaluate the role of physician experience on rates of plasma HIV-1 RNA suppression following initiation of ART. Methods: Using data from a community-recruited cohort of HIV-positive illicit drug users, we used Cox proportional hazards regression to model the time to plasma viral HIV RNA < 500 copies/mL among antiretroviral-naïve subjects initiating ART. Physician experience was defined as a continuous variable measured per 100 HIV-infected patients previously enrolled in the province-wide HIV treatment registry by that physician at the time a patient was enrolled. Results: Between May 1996 and December 2008, 267 individuals initiated ART among whom 227 (85%) achieved a plasma HIV RNA < 500 copies/mL during the study period. In a multivariate analysis, greater physician experience was independently associated with higher rates of plasma HIV RNA suppression (adjusted hazard ratio [AHR] = 1.17, 95% confidence interval [CI]: 1.03-1.34) after adjustment for adherence to ART. Other factors associated with viral suppression included engagement in methadone maintenance therapy (AHR = 1.61, 95% CI: 1.23-2.09), ≥ 95% adherence to ART (AHR = 2.42, 95% CI: 1.80-3.26), baseline CD4 count (AHR = 0.89, 95% CI: 0.83-0.96) and baseline plasma HIV-1 RNA (AHR = 0.65, 95% CI: 0.53-0.81). Conclusions: In this setting of universal HIV/AIDS care, illicit drug users with more experienced physicians exhibited faster rates of plasma viral load suppression. These findings argue for specialized services to help optimize HIV treatment outcomes among this population.